News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Job Trends
Novalar Pharmaceuticals, Inc. Plans Shutdown Following Sale of OraVerse to Septodont, to Cut 12 Jobs
March 23, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Xconomy -- It turns out that Novalar Pharmaceuticals’ decision to sell OraVerse, its dental anesthesia reversal agent, was only half the story.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
MORE ON THIS TOPIC
Job Trends
Greener Pastures? 81% of Employed Biopharma Professionals Want New Jobs,
BioSpace
Finds
July 31, 2025
·
4 min read
·
Angela Gabriel
Job Trends
7 Companies Hiring in North Carolina
July 31, 2025
·
1 min read
·
Angela Gabriel
Job Trends
Amidst Industry Challenges, 85% of Pharmas Increase Investment in AI
July 31, 2025
·
4 min read
·
Angela Gabriel
Layoffs
Tales of the Weird: How Some Biopharma Employees Found Out About Layoffs
July 24, 2025
·
4 min read
·
Angela Gabriel
